Project overview
Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition of the lungs where tissue becomes thickened, stiff, and scarred, limiting the amount of oxygen getting into the blood. The aim of this project is to provide effective targeted therapies for sufferers to reduce symptoms of this devastating disease and improve their quality of life as well as to identify biomarkers for IPF patients.
Staff
Lead researcher
Collaborating research institutes, centres and groups
Research outputs
Liudi Yao,
Yilu Zhou,
Juanjuan Li,
Leanne Wickens,
Franco Conforti,
Anna Simron Rattu,
Fathima M Ibrahim,
Aiman Alzetani,
Sophie Fletcher,
David Hancock,
Timothy Wallis,
Julian Downward,
Luca Richeldi,
Mark Glynne Jones,
, 2021
, The Journal of Biological Chemistry
, 297 (3)
Type: article
Franco Conforti,
Robert Ridley,
Christopher J Brereton,
Aiman Alzetani,
Yihua Wang,
Christian Ottensmeier,
B. Marshall,
Sophie Fletcher,
Luca Richeldi,
Benjamin Johnson,
&
, 2020
, Cell Death and Discovery
, 6
Type: article
Dian Liu,
Ayse Ertay,
Charlotte Hill,
Yilu Zhou,
Juanjuan Li,
Yanmei Zou,
Hong Qiu,
Xianglin Yuan,
Xin Lu,
Hua Xiong,
& Yihua Wang
, 2020
, Cell Death and Disease
, 11 (4)
Type: article
Xiaofan Liu,
Hong Zhou,
Yilu Zhou,
Xiaojun Wu,
Yang Zhao,
Yang Lu,
Weijun Tan,
Mingli Yuan,
Xuhong Ding,
Jinjing Zou,
Ruiyun Li,
Hailing Li,
Yi Hu,
Hanxiang Nie,
& Yihua Wang
, 2020
, Scientific Reports
, 10 (1)
Type: article
Xiaojun Wu,
Tong Wang,
Yilu Zhou,
Xiaofan Liu,
Hong Zhou,
Yang Lu,
Weijun Tan,
Mingli Yuan,
Xuhong Ding,
Jinjing Zou,
Ruiyun Li,
Hailing Liu,
Yi Hu,
Hanxiang Nie,
& Yihua Wang
, 2020
, Virologica Sinica
, 1--4
Type: letterEditorial
Pagination
-
- 1
- 2
- 3
- 4